share_log

華領醫藥-B：致非登記股東之通知信函 - 以電子方式發布企業通訊之安排及申請表格

HUA MEDICINE-B: Notification Letter to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Request Form

HKEX ·  Jun 27 18:14

Summary by Moomoo AI

華領醫藥於2024年6月27日宣布，根據香港聯合交易所有限公司證券上市規則的修訂，自2023年12月31日起，公司將採用電子方式發布公司通訊。未來，公司通訊將不再郵寄印刷本給非登記股東，除非收到個別股東的要求。公司通訊的中英文版本將可在華領醫藥及聯交所的網站上獲得。若股東提供有效的電郵或郵寄地址，公司將發送有關網站版本通訊的發布通知。股東如需繼續收取印刷本，需填寫申請表格並於2024年12月31日前提交。此外，股東可隨時透過電話或電郵聯繫股份過戶登記處查詢。
華領醫藥於2024年6月27日宣布，根據香港聯合交易所有限公司證券上市規則的修訂，自2023年12月31日起，公司將採用電子方式發布公司通訊。未來，公司通訊將不再郵寄印刷本給非登記股東，除非收到個別股東的要求。公司通訊的中英文版本將可在華領醫藥及聯交所的網站上獲得。若股東提供有效的電郵或郵寄地址，公司將發送有關網站版本通訊的發布通知。股東如需繼續收取印刷本，需填寫申請表格並於2024年12月31日前提交。此外，股東可隨時透過電話或電郵聯繫股份過戶登記處查詢。
On June 27, 2024, Hua Ling Pharmaceutical announced that, in accordance with the revised Securities Listing Rules of the Hong Kong Stock Exchange, the company will use electronic means to publish company communications from December 31, 2023. In the future, company communications will no longer be mailed in print to non-registered shareholders, unless requested by individual shareholders. The Chinese and English versions of the company's communications will be available on Hua Ling Pharmaceutical's and the Stock Exchange's websites. If shareholders provide a valid email or mailing address, the company will send notices regarding the release of website version communications. If shareholders wish to continue receiving printed copies, they must complete an application form and submit it before December 31, 2024. In addition, shareholders can contact the share registrar by telephone or email at any time for inquiries.
On June 27, 2024, Hua Ling Pharmaceutical announced that, in accordance with the revised Securities Listing Rules of the Hong Kong Stock Exchange, the company will use electronic means to publish company communications from December 31, 2023. In the future, company communications will no longer be mailed in print to non-registered shareholders, unless requested by individual shareholders. The Chinese and English versions of the company's communications will be available on Hua Ling Pharmaceutical's and the Stock Exchange's websites. If shareholders provide a valid email or mailing address, the company will send notices regarding the release of website version communications. If shareholders wish to continue receiving printed copies, they must complete an application form and submit it before December 31, 2024. In addition, shareholders can contact the share registrar by telephone or email at any time for inquiries.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated